CISI FIN (06058) is offering for sale a total of $7 million in notes.
Guotai Junan International (06058) issued an announcement. The company's indirectly wholly-owned subsidiary, CISI Investment...
CISI FIN (06058) announced that its indirect wholly-owned subsidiary, CISI Investment, sold notes with a principal amount totaling $7 million (approximately HK$54.95 million) on the open market on January 3, 2025, and January 9, 2025, for a total consideration of approximately $6.9869 million.
Related Articles
.png)
ShenZhen New Industries Biomedical Engineering(300832.SZ) obtained a medical device registration certificate.
UNITED LAB (03933): Moxifloxacin hydrochloride eye drops have been approved by the National Medical Products Administration for market authorization.
BJ ENT WATER (00371) completes the issuance of 1 billion yuan medium-term notes.
ShenZhen New Industries Biomedical Engineering(300832.SZ) obtained a medical device registration certificate.
UNITED LAB (03933): Moxifloxacin hydrochloride eye drops have been approved by the National Medical Products Administration for market authorization.
BJ ENT WATER (00371) completes the issuance of 1 billion yuan medium-term notes.
RECOMMEND
Baidu’s AI Ace Kunlunxin Prepares For Hong Kong IPO, Domestic Computing Power Faces Crucial Test
08/12/2025
Institutions Say Short-Term Volatility Does Not Alter Upward Trend Of Hong Kong Stocks, Hang Seng Index Still Expected To Challenge 30,000 Points Next Year
08/12/2025
As The 2025 Central Economic Work Conference Approaches, What New Expectations Lie Ahead For Next Year’s Economic Agenda? Institutions Forecast Five Key Highlights
08/12/2025
